INVO Fertility, Inc. (IVF) vs Propanc Biopharma, Inc. (PPCB)

A side-by-side comparison of INVO Fertility, Inc. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IVF vs PPCB

growth of $100 · dividends reinvested · last 10y
IVF -100.0% (-58.2%/yr)PPCB -100.0% (-89.4%/yr)IVF compounded faster over this window
Log scale — wide-divergence pair
000000001101001kStart $10020172019202120232025$0$0
IVF PPCB

IVF vs PPCB: by the numbers

  • •IVF is the larger company ($1M vs $1M market cap).
  • •Both run net losses; PPCB's is the smaller (0.00% vs -70.18% net margin).

Metrics side by side

Valuation

MetricIVFPPCB
P/S ratio0.19N/A
P/B ratio0.090.12

Profitability

MetricIVFPPCB
Gross margin33.34%0.00%
Operating margin-78.72%0.00%
Net margin-70.18%0.00%
ROE-32.05%-200.63%
ROIC-28.43%-183.49%

Growth (annualized)

MetricIVFPPCB
Revenue CAGR (5Y)39.51%N/A
Total return CAGR (5Y)-90.41%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.